Uğur Şahin

faz.net/aktuell/finanzen/boersenwoche-hilft-beau7y-gegen-vergaenglichkeit-19604722.html

Mar 22

Börsenwoche: Does BEAU7Y help against transience?: The stock exchanges have found their messiah in Nvidia and its boss Jensen Huang. But what's going on with his ...

deraktionaer.de/artikel/pharma-biotech/biontech-spannende-kooperation-aktie-zieht-an-20349999.html

0

MSV Duisburg Feb 07

Two of our Zebra talents, Emre Çil (U19) and Uğur Şahin (U17), are currently with their respective Turkish junior national teams ... Show more #WeilDUesBist

0

Feb 08

BioNTech: Exciting cooperation - Stock is rising: BioNTech partners with Autolus to develop CAR T-cell therapies against cancer.

0

Der Spiegel (online)

spiegel.de/wirtschaft/unternehmen/biontech-warum-das-unternehmen-jetzt-in-ruanda-impfstoff-herstellen-will-a-a301130d-2fb0-4f7a-a386-b6b032ec5c77

Dec 18 23

Mainz-based company: Why Biontech now wants to produce vaccine in Rwanda: When the German Foreign Minister travels to Kigali for a factory inauguration ...

Quick Glance: Biontech: Vaccine Production in Rwanda

Biontech plans new vaccine production in Rwanda in partnership with Rheinland-Pfalz.

Planned production of 50 million vaccine doses per year, with potential for more.

Rwanda as a relatively safe and stable partner country for Biontech.

Biontech subsidiary, Instadeep, also opens branch in Kigali.

1.3k

Dec 19 23

'Africa will have one of the most advanced manufacturing facilities in the world,' said Ugur Sahin, BioNTech co-founder and chief executive officer as the ... Show more

40

8

ZDF

zdf.de/nachrichten/wissen/biontech-krebs-forschung-impfstoff-100.html

Nov 26 23

Cancer vaccines: Biontech plans therapeutic approach before 2030: Can we soon hope for an alternative to chemotherapy in the fight against cancer? The head of ...

Quick Glance: Revolutionary: Biontech's Customized Cancer Vaccines by 2030

Innovative treatment alternative: Biontech plans individualized cancer vaccines by 2030

CEO Ugur Sahin anticipates soon development of a cancer vaccine.

Hope in the fight against cancer through Biontech.

Advances in personalized cancer therapy by Biontech by 2030.

2 similar articles

2.7k

1.2k

Focus (Polish magazine)

D+

Nov 26 23

Biontech plans anti-cancer vaccines for tens of thousands of patients by 2030: The fight against cancer could soon take other forms. Biontech is researching new ...

focus.de/gesundheit/news/tumor-zielgerichtet-finden-und-zerstoeren-anti-krebs-spritze-von-biontech-koennte-bereits-2030-zugelassen-werden_id_252634243.html

Quick Glance: Biontech Plans Anti-Cancer Vaccines for Thousands of Patients by 2030

New forms of fighting cancer on the horizon

Market launch of anti-cancer vaccine planned by 2030

Expected approval of personalized mRNA-based cancer vaccines before 2030

Positive results in tumor growth and shrinkage for almost all patients

450

Nov 06 23

Although BioNTech recorded a slump of around 90 percent after the billion-dollar profits from the previous year, the CEO was confident ... Show more ow.ly/FYuJ50Q4xrn

Quick Glance: Biontech Surprises with Profit Despite Downturn

Biontech achieves profit in current quarterly numbers despite losses reported by other vaccine manufacturers.

Biontech's strategy enables profit despite challenges.

Biontech demonstrates cautious approach compared to previous actions.

6 similar articles

0

10

faz.net/aktuell/rhein-main/biontech-gruender-sahin-zulassungen-neuer-krebsmittel-ab-2026-moeglich-19116107.html

Aug 23 23

Biontech founder Ugur Sahin: "Approvals of new cancer drugs possible from 2026": Corona is under control, now Biontech founder Ugur Sahin is primarily dedicated ...

Paid articlePaid

Quick Glance: Biontech Founder Ugur Sahin: New Cancer Drugs Possible from 2026

Biontech Founder Ugur Sahin focuses on developing new cancer therapies.

We have a CAR-T cell therapy in clinical testing and several antibody candidates in development.

Our vision is to personalize cancer treatment using mRNA technology.

We develop therapeutic vaccines that present tumor-specific characteristics to the patient's immune system.

64

Aug 09 23

Biontech: New vaccine in September: In the second quarter, the vaccine manufacturer Biontech had to accept a loss. An adapted corona vaccine will soon be on the ...

nw.de/nachrichten/wirtschaft/wirtschaftsnachrichten/23631526_Biontech-Neuer-Impfstoff-im-September.html

Quick Glance: Biontech hopes for adapted Covid vaccine in the fall

Biontech experiences quarterly loss due to unsold inventory.

Corona boom comes to a sudden end at Biontech.

Biontech reports a net loss of 190 million euros in the second quarter.

Biontech expects a revenue of 5 billion euros from Covid vaccines this year.

30 similar articles

35

33

MSV Duisburg Sep 06 23

🇹🇷 Batu Yavuz & Uğur Şahin are representing our blue and white zebra stripes on the international stage these days. We wish: Bol şans! 🍀 More on this ➡️ ... Show more ww.msv-duisburg.de/aktuelles/artikel/zebratalente-sahin-am-bosporus-yavuz-am-schwarzen-meer/ #WeilDUesBist

0

Aug 22 23

BioNTech steps on the gas - CEO criticizes: At the start of the week, BioNTech shares made a significant jump in price.

deraktionaer.de/artikel/aktien/biontech-gibt-gas-ceo-uebt-kritik-20338066.html

rheinpfalz.de/politik/rheinland-pfalz_artikel,-biontech-k%C3%B6nnen-rasch-auf-neue-corona-varianten-reagieren-_arid,5510403.html

0

MSV Duisburg Aug 06 23

𝗗𝗘𝗥𝗕𝗬𝗦𝗜𝗘𝗚! 💥 The MSV-U17 starts in the B-Junior Bundesliga with a 2:1 win against RWO. Mo Berrahou & Ugur Sahin scored for our Zebra Talents ... Show more #WeilDUesBist

0

May 25 23

Biontech: Can react quickly to new corona variants: The boss of the vaccine manufacturer Biontech expects the presence of the Sars-CoV-2 coronavirus to continue ...

3 similar articles

5

.

wiesbadener-kurier.de

B-

May 16 23

Video puts false statements in Biontech founder's mouth: A manipulated video with Biontech boss Uğur Şahin has appeared on the Internet, in which he appears to ...

wiesbadener-kurier.de/wirtschaft/wirtschaft-deutschland/video-legt-biontech-gruender-falsche-aussagen-in-den-mund-2552006

4 similar articles

12

4

faz.net/aktuell/wirtschaft/unternehmen/wie-biontech-auch-ohne-den-corona-notstand-erfolgreich-ist-18878586.html

May 09 23

After the Corona vaccination: how Biontech succeeds without an emergency: Where do things go from here in Mainz? Biontech is pinning its hopes on oncology ...

14

Apr 14 23

Ozlem Tureci and Ugur Sahin: Find out why Ozlem Tureci and Ugur Sahin is one of the 100 most influential people of 2023.

time.com/collection/100-most-influential-people-2023/6270459/ozlem-tureci-and-ugur-sahin/

47

Mar 28 23

Biontech to invest Corona billions in cancer research: Biontech made more than 9 billion euros in profits in 2022 thanks to the Corona vaccine ...

stern.de/wirtschaft/news/biontech-will-corona-milliarden-in-krebsforschung-investieren-33322230.html

1 similar article

669

293

faz.net/aktuell/wirtschaft/krebsbehandlung-von-biontech-soll-bis-2030-alltag-werden-18690208.html

Feb 19 23

mRNA technology: cancer treatment from Biontech to become commonplace by 2030: Clinical trials in the UK are to start soon to bring Biontech's cancer drug to ...

344

Feb 19 23

Patient and site selection: Biontech gets cancer vaccine trials underway: In the UK, Biontech founders Sahin and Türeci want the first patients to soon receive ...

n-tv.de/wissen/Biontech-bringt-Studien-zu-Krebsimpfung-auf-den-Weg-article23928883.html

283

Jan 24 23

Biontech leaves Germany for cancer research: Company founders Ugur Sahin and Özlem Türeci are bothered by German bureaucracy. They are apparently outsourcing ...

berliner-zeitung.de/news/bericht-biontech-verlaesst-deutschland-fuer-die-krebsforschung-li.310200

59

Mar 01 23

These are the largest shareholders in the corona vaccine developer BioNTech: The news of a reliable corona vaccine from BioNTech not only made the stock market ...

finanzen.net/nachricht/aktien/18-in-gruenderhand-das-sind-die-groessten-anteilseigner-des-corona-impfstoffentwicklers-biontech-9593919

0

Jan 22 23

How Biontech boss Sahin wants to decode cancer: Artificial intelligence aims to accelerate Biontech's cancer research. In the "Stern" podcast "A new medicine - ...

n-tv.de/wissen/Wie-Biontech-Chef-Sahin-den-Krebs-entschluesseln-will-article23855032.html

163

Jan 10 23

Does mRNA promise a revolution in medicine? @natashaloder talks to Ugur Sahin of BioNTech on “Babbage”, our podcast on science and technology, hosted by @alokjha

BioNTech’s founder on the future of mRNA technology: Our podcast on science and technology. This week, Ugur Sahin tells us how mRNA will help fight pandemics and ...

economist.com/podcasts/2023/01/04/biontechs-founder-on-the-future-of-mrna-technology

107

Dec 31 22

Biontech founders: they have been working on vaccination against cancer for more than 20 years

stern.de/panorama/wissen/biontech-gruender--seit-mehr-als-20-jahren-arbeiten-sie-an-impfung-gegen-krebs-33052250.html

150

Jan 10 23

How will mRNA vaccines keep up with new variants of the coronavirus? BioNTech co-founder Ugur Sahin talks to @natashaloder on “Babbage” ... Show more

BioNTech’s founder on the future of mRNA technology: Our podcast on science and technology. This week, Ugur Sahin tells us how mRNA will help fight pandemics and ...

economist.com/podcasts/2023/01/04/biontechs-founder-on-the-future-of-mrna-technology

37

Jan 06 23

“We believe that this is going to be the future of cancer treatment.” Ugur Sahin of @BioNTech_Group tells @natashaloder how mRNA technology can help to fight diseases ... Show more econ.st/3VNcef8

94

Dec 15 22

Stopping cancer, stopping aging: That's what the Biontech founders plan to do with their vaccine billions

n-tv.de/wirtschaft/Das-haben-die-Biontech-Gruender-mit-ihren-Impfstoff-Milliarden-vor-article23782548.html

102

Jan 15 23

BioNTech (Not Pfizer) “brazenly” dodged safety testing of Covid-19 vaccine - The Rio Times

riotimesonline.com/brazil-news/modern-day-censorship/biontech-not-pfizer-brazenly-dodged-safety-testing-of-covid-19-vaccine/

0

Hellweger Anzeiger

C

Jan 11 23

Biontech relies on artificial intelligence: Largest takeover planned in company history

ruhrnachrichten.de/ueberregionales/biontech-firmenuebernahme-kuenstliche-intelligenz-w682349-2000717380/

2 similar articles

0

DER AKTIONÄR

C

Jan 11 23

BioNTech: Gains after acquisition - this hurdle is important now: After the recent consolidation, the BioNTech share was able to increase again on Tuesday.

deraktionaer.de/artikel/pharma-biotech/biontech-zugewinne-nach-uebernahme-diese-huerde-ist-jetzt-wichtig-20324275.html

0

Dec 15 22

stern editor-in-chief on the new issue: fathers, Reich citizens, biontech: In the current issue of stern, we ask ourselves what a modern father looks like ...

stern.de/gesellschaft/stern-chefredakteur-ueber-das-neue-heft--vaeter--reichsbuerger--biontech-33006970.html